UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005883
Receipt number R000006942
Scientific Title The effect of combination therapy of Donepezil and Memary for moderate to severe Alzheimer's disease
Date of disclosure of the study information 2011/09/01
Last modified on 2017/07/03 18:53:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of combination therapy of Donepezil and Memary for moderate to severe Alzheimer's disease

Acronym

The effect of combination therapy of Donepezil and Memary for moderate to severe Alzheimer's disease

Scientific Title

The effect of combination therapy of Donepezil and Memary for moderate to severe Alzheimer's disease

Scientific Title:Acronym

The effect of combination therapy of Donepezil and Memary for moderate to severe Alzheimer's disease

Region

Japan


Condition

Condition

moderate to severe Alzheimer's disease

Classification by specialty

Neurology Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will examine both usefulness and safety about combination therapy of Donepezil and Memantine.

Basic objectives2

Others

Basic objectives -Others

We will utilize the results mentioned above for the new strategic drug therapy for the patients of Alzheimer's disease.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase IV


Assessment

Primary outcomes

We will carry out tree contents of SIB, FAST and MMSE for 3 times at every 12 week-point during 24 weeks from the start-point of medication and evaluate the results of usefulness.

Key secondary outcomes

We will carry out two contents of NPI-D and ADCS-ADL for 3 times at every 12 week-point during 24 weeks from the start-point of medication and evaluate the results of usefulness.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Group A;At first, donepezil (10mg/day) for 24weeks continuously. Memantine is added at 5mg/day (W13)to 20mg/day at W16 (+5mg/day per every 1 week). As a result, donepezil (10mg/day) +memantine (20mg/day) from W16 to W24.
The number of times of medication: 1/day

Interventions/Control_2

Group B;At first, donepezil is fixed at 5mg/day continuously from W1 to W13. And from W14 to W24, donepezil is up to 10mg/day. Memantine start from W1 at 5mg/day and adding up to 20mg/day at W4 (+5mg/day per every 1 week). As a result, from W4 to W24, memantine is continuously fixed at 20mg/day.
As a result, donepezil (10mg/day) +memantine (20mg/day) from W13 to W24.
The number of times of medication: 1/day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Inclusion Criteria:Diagnosed as Alzheimer's disease with DSM-4.
Severity of dementia: FAST5-6.
Medication: Donepezil 5mg/day >=6 months continuously as stable.

Key exclusion criteria

Patients with contraindication for donepezil or/and memantine.
Patients who is judged as inappropriate for entry to this study.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name YASUJI YAMAMOTO

Organization

Kobe University Graduate School of Medicine

Division name

Department of Psychiatry

Zip code


Address

7-5-2, Kusuniki-cho, Chuo-ku, Kobe, Hyogo

TEL

078-382-6065

Email

yamay@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name YASUJI YAMAMOTO

Organization

Kobe University Graduate School of Medicine

Division name

Department of Psychiatry

Zip code


Address

7-5-2, Kusuniki-cho, Chuo-ku, Kobe, Hyogo

TEL

078-382-6065

Homepage URL


Email

yamay@med.kobe-u.ac.jp


Sponsor or person

Institute

YASUJI YAMAMOTO

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

神戸大学附属病院(兵庫県神戸市)


Other administrative information

Date of disclosure of the study information

2011 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2011 Year 08 Month 31 Day

Date of IRB


Anticipated trial start date

2011 Year 09 Month 01 Day

Last follow-up date

2016 Year 03 Month 01 Day

Date of closure to data entry

2016 Year 09 Month 01 Day

Date trial data considered complete

2017 Year 03 Month 01 Day

Date analysis concluded

2017 Year 07 Month 03 Day


Other

Other related information



Management information

Registered date

2011 Year 06 Month 29 Day

Last modified on

2017 Year 07 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006942


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name